메뉴 건너뛰기




Volumn 1, Issue 4, 2014, Pages 166-171

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

(143)  Brandes, Alba A a   Franceschi, Enrico a   Ermani, Mario b   Tosoni, Alicia a   Albani, Fiorenzo c,d   Depenni, Roberta e   Faedi, Marina f   Pisanello, Anna g   Crisi, Girolamo h   Urbini, Benedetta i   Dazzi, Claudio j   Cavanna, Luigi k   Mucciarini, Claudia l   Pasini, Giuseppe m   Bartolini, Stefania a   Marucci, Gianluca d   Morandi, Luca d   Zunarelli, Elena e   Cerasoli, Serenella n   Gardini, Giorgio g   more..


Author keywords

Center volume; Glioblastoma; Radiotherapy; Surgery; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

EID: 84964073377     PISSN: 20542577     EISSN: 20542585     Source Type: Journal    
DOI: 10.1093/nop/npu021     Document Type: Article
Times cited : (34)

References (19)
  • 1
    • 84862016066 scopus 로고    scopus 로고
    • Epidemiology of glial and non-glial brain tumours in Europe
    • Crocetti E, Trama A, Stiller C, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012;48(10):1532-1542.
    • (2012) Eur J Cancer , vol.48 , Issue.10 , pp. 1532-1542
    • Crocetti, E.1    Trama, A.2    Stiller, C.3
  • 2
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
    • (2009) Lancet Oncol , vol.10 , Issue.5 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3
  • 3
    • 20044366163 scopus 로고    scopus 로고
    • Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    • Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
    • (2005) N Engl J Med , vol.352 , Issue.10 , pp. 987-996
    • Stupp, R.1    Mason, W.P.2    van den Bent, M.J.3
  • 4
    • 84878331540 scopus 로고    scopus 로고
    • Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain
    • Graus F, Bruna J, Pardo J, et al. Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain. Neuro Oncol. 2013;15(6):797-805.
    • (2013) Neuro Oncol , vol.15 , Issue.6 , pp. 797-805
    • Graus, F.1    Bruna, J.2    Pardo, J.3
  • 5
    • 84863562673 scopus 로고    scopus 로고
    • Glioblastoma survival in the United States before and during the temozolomide era
    • Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2011; 107(2):359-364.
    • (2011) J Neurooncol , vol.107 , Issue.2 , pp. 359-364
    • Johnson, D.R.1    O'Neill, B.P.2
  • 6
    • 84859530078 scopus 로고    scopus 로고
    • Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
    • YabroffKR, Harlan L, Zeruto C, et al. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro Oncol. 2012;14(3):351-359.
    • (2012) Neuro Oncol , vol.14 , Issue.3 , pp. 351-359
    • Yabroff, K.R.1    Harlan, L.2    Zeruto, C.3
  • 7
    • 0026749893 scopus 로고
    • The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies
    • Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135(9):1060-1067.
    • (1992) Am J Epidemiol , vol.135 , Issue.9 , pp. 1060-1067
    • Hook, E.B.1    Regal, R.R.2
  • 8
    • 33750580929 scopus 로고    scopus 로고
    • Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study
    • Brandes AA, Tosoni A, Cavallo G, et al. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol. 2006;24(29):4746-4753.
    • (2006) J Clin Oncol , vol.24 , Issue.29 , pp. 4746-4753
    • Brandes, A.A.1    Tosoni, A.2    Cavallo, G.3
  • 9
    • 84891785971 scopus 로고    scopus 로고
    • Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
    • Gilbert MR, Wang M, Aldape KD, et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol. 2013;31(32):4085-4091.
    • (2013) J Clin Oncol , vol.31 , Issue.32 , pp. 4085-4091
    • Gilbert, M.R.1    Wang, M.2    Aldape, K.D.3
  • 10
    • 84886591961 scopus 로고    scopus 로고
    • Glioblastoma management in the temozolomide era: have we improved outcome?
    • Lwin Z, MacFadden D, Al-Zahrani A, et al. Glioblastoma management in the temozolomide era: have we improved outcome?. J Neurooncol. 2013;115(2):303-310.
    • (2013) J Neurooncol , vol.115 , Issue.2 , pp. 303-310
    • Lwin, Z.1    MacFadden, D.2    Al-Zahrani, A.3
  • 11
    • 84861328546 scopus 로고    scopus 로고
    • Improved survival time trends for glioblastoma using the SEER 17 population-based registries
    • Koshy M, Villano JL, Dolecek TA, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012;107(1):207-212.
    • (2012) J Neurooncol , vol.107 , Issue.1 , pp. 207-212
    • Koshy, M.1    Villano, J.L.2    Dolecek, T.A.3
  • 12
    • 85047052863 scopus 로고    scopus 로고
    • Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide (TMZ) therapy for high-grade gliomas (HGG) in Colombia (RedLANO registry)
    • Ortiz LD, Cardona AF, Fadul CE, et al. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide (TMZ) therapy for high-grade gliomas (HGG) in Colombia (RedLANO registry). ASCO Meeting Abstracts. 2011;29(15_suppl):2092.
    • (2011) ASCO Meeting Abstracts , vol.29 , Issue.15 , pp. 2092
    • Ortiz, L.D.1    Cardona, A.F.2    Fadul, C.E.3
  • 13
    • 84881536183 scopus 로고    scopus 로고
    • Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry
    • Woehrer A. Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry. Clin Neuropathol. 2013;32(4):269-285.
    • (2013) Clin Neuropathol , vol.32 , Issue.4 , pp. 269-285
    • Woehrer, A.1
  • 14
    • 20344407807 scopus 로고    scopus 로고
    • Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
    • Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479-489.
    • (2005) J Neuropathol Exp Neurol , vol.64 , Issue.6 , pp. 479-489
    • Ohgaki, H.1    Kleihues, P.2
  • 15
    • 84857061372 scopus 로고    scopus 로고
    • Patterns of care and survival for glioblastoma patients in the Veterans population
    • Arrigo RT, Boakye M, Skirboll SL. Patterns of care and survival for glioblastoma patients in the Veterans population. J Neurooncol. 2011;106(3):627-635.
    • (2011) J Neurooncol , vol.106 , Issue.3 , pp. 627-635
    • Arrigo, R.T.1    Boakye, M.2    Skirboll, S.L.3
  • 16
    • 84886515453 scopus 로고    scopus 로고
    • High procedure volume is strongly associated with improved survival after lung cancer surgery
    • Luchtenborg M, Riaz SP, Coupland VH, et al. High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol. 2013;31(25):3141-3146.
    • (2013) J Clin Oncol , vol.31 , Issue.25 , pp. 3141-3146
    • Luchtenborg, M.1    Riaz, S.P.2    Coupland, V.H.3
  • 17
    • 0036037267 scopus 로고    scopus 로고
    • The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer
    • Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89(8): 1008-1013.
    • (2002) Br J Surg , vol.89 , Issue.8 , pp. 1008-1013
    • Martling, A.1    Cedermark, B.2    Johansson, H.3
  • 18
    • 84879072261 scopus 로고    scopus 로고
    • Adherence to treatment guidelines for ovarian cancer as a measure of quality care
    • Bristow RE, Chang J, Ziogas A, et al. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121(6):1226-1234.
    • (2013) Obstet Gynecol , vol.121 , Issue.6 , pp. 1226-1234
    • Bristow, R.E.1    Chang, J.2    Ziogas, A.3
  • 19
    • 84875418001 scopus 로고    scopus 로고
    • Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study
    • Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study. J Clin Oncol. 2013;31(5):551-557.
    • (2013) J Clin Oncol , vol.31 , Issue.5 , pp. 551-557
    • Derogar, M.1    Sadr-Azodi, O.2    Johar, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.